T. Rowe Price Associates’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-223,127	Closed	-$3.18M	–	3018
2021 Q2	$3.18M	Sell	223,127 -11,139	-5%	-$159K	﹤0.01%	1598
2021 Q1	$989K	Hold	234,266	–	–	﹤0.01%	2049
2020 Q4	$1.32M	Buy	+234,266	New	+$1.32M	﹤0.01%	1809